No Detail Found!

Improvement in hemodynamics of amlodipine besylate combined with metoprolol in patients with hypertension complicated by heart failure

Author(s)
Chen Chen Department of Cardiology, Nanjing Brain Hospital Affiliated to Nanjing Medical University,Nanjing, Jiangsu,China
Wenyu Zhang Department of Cardiology, Nanjing Brain Hospital Affiliated to Nanjing Medical University,Nanjing, Jiangsu,China
Dongdong Jiao Department of Cardiology, Nanjing Brain Hospital Affiliated to Nanjing Medical University,Nanjing, Jiangsu,China
Jing Shen Department of Cardiology, Nanjing Brain Hospital Affiliated to Nanjing Medical University,Nanjing, Jiangsu,China
Guangjian Zhu Department of Cardiology, Nanjing Brain Hospital Affiliated to Nanjing Medical University,Nanjing, Jiangsu,China
Xinlei Zhang Department of Cardiology, Nanjing Brain Hospital Affiliated to Nanjing Medical University,Nanjing, Jiangsu,China
Abstract
To observe the effect of amlodipine besylate combined with metoprolol in treating hypertension and heart failure. Total number of patients with hypertension combined with HF admitted to our hospital was One hundred and fifty from May 2017 to May 2022 selected for the study and they were distributed into single drug group and combination group by the method of random number table, with the total number of 75 cases in every group. Metoprolol treatment was given to the single drug group and metoprolol combined with amlodipine besylate treatment was given to the combination group. Both groups' scientific outcomes were compared, including their ventricular function, inflammatory factors, hemodynamics and liver and kidney function. Adverse treatment-related side events for patients were also tallied. Compared to the single drug group, the combination group's overall treatment effectiveness was higher (P0.05). Amlodipine besylate combined with metoprolol has a better clinical effect in treating hypertension combined with heart failure, which can more effectively improve patients' cardiac function, inflammation and hemodynamics.
Publication Details
Page(s) 909-914
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: S3, Year: 2023

Request the full text from PASTIC

Keywords
Hypertension, Metoprolol, Hemodynamics, Heart failure, Amlodipine besylate
References
Al Ghorani H,Gotzinger F,Bohm M,Mahfoud F M .2022 .. Arterial hypertension - Clinical trials update 2021. Nutr, 32(1) : 21-31.
Alpsoy S .2020 .Exercise and hypertension. Adv. Exp. Med, 1228 : 153-167.
Boulestreau R,van den Born BH,Lip GYH,Gupta A .2022 .Malignant hypertension: Current perspectives and challenges. J. Am. Heart Assoc, 11(7) : e023397.
Chennamadhavuni A,Abushahin L,Jin N,Presley CJ,Manne A .2022 .Risk factors and biomarkers for immune-related adverse events: A practical guide to identifying high-risk patients and rechallenging immune checkpoint inhibitors. Front. Immunol, 13 : 779691.
De Becker B and Van de Borne P .2018 .Treatment of hypertension to prevent atrial fibrillation. Curr. Pharm Des, 24(37) : 4397-4403.
de Leeuw PW,Kroon AA .1998 .Hypertension and the development of heart failure. J. Cardiovasc. Pharmacol., 32(Suppl 1) : S9-S15.
Di Palo KE,Barone NJ .2020 .Hypertension and heart failure: Prevention, targets and treatment. Heart Fail. Clin., 16(1) : 99-106.
Di Palo KE,Barone NJ .2022 .Hypertension and heart failure: Prevention, targets and treatment. , 40(2) : 237-244.
Dikalova AE,Pandey A,Xiao L,Arslanbaeva L,Sidorova T,Lopez MG,Billings FTt,Verdin E,Auwerx J,Harrison DG,Dikalov SI .2020 .Mitochondrial deacetylase sirt3 reduces vascular dysfunction and hypertension while sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress. Circ. Res., 126(4) : 439-452.
Engeli S,Stinkens R,Heise T,May M,Goossens GH,Blaak EE,Havekes B,Jax T,Albrecht D,Pal P,Tegtbur U,Haufe S,Langenickel TH,Jordan J .2018 .Effect of sacubitril/valsartan on exercise-induced lipid metabolism in patients with obesity and hypertension. Hypertension, 71(1) : 70-77.
Ferreira NS,Tostes RC,Paradis P,Schiffrin EL .2021 .Aldosterone, inflammation, immune system, and hypertension. Am. J. Hypertens., 34(1) : 15-27.
Grassi G .2018 .Metoprolol in the treatment of cardiovascular disease: A critical reappraisal. Curr. Med. Res. Opin., 34(9) : 1635-1643.
Hendriksen LC,Omes-Smit G,Koch BCP,Ikram MA,Stricker BH,Visser LE .2022 .Sex-based difference in the effect of metoprolol on heart rate and bradycardia in a population-based setting. J. Pers. Med, 12(6) : 870.
Jackson AM,Jhund PS,Anand IS,Dungen HD,Lam CSP,Lefkowitz MP,Linssen G,Lund LH,Maggioni AP,Pfeffer MA,Rouleau JL,Saraiva JFK,Senni M,Vardeny O,Wijkman MO,Yilmaz MB,Saito Y,Zile MR,Solomon SD,McMurray JJV .2021 .Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. Eur. Heart J., 42(36) : 3741-3752.
Johnson K,Oparil S,Davis BR,Tereshchenko LG .2019 .Prevention of heart failure in hypertensiondisentangling the role of evolving left ventricular hypertrophy and blood pressure lowering: The ALLHAT study. J. Am Heart Assoc., 8(8) : e011961.
Juraschek SP,Appel LJ,Miller ER,Mukamal KJ,Lipsitz LA .2018 .Hypertension treatment effects on orthostatic hypotension and its relationship with cardiovascular disease. Hypertension, 72(4) : 986-993.
Kanorskii SG,Sereda AF .2016 .Comparison of verapamil and amlodipine for treatment of chronic heart failure with preserved left ventricular ejection fraction in patients with hypertensive disease. Kardiologiia., 56(12) : 27-32.
Lamirault G,Artifoni M,Daniel M,Barber-Chamoux N .2020 .Resistant Hypertension: Novel Insights. Curr Hypertens Rev., 16(1) : 61-72.
Lee HW,Huang CC,Leu HB,Lin YJ .2022 .Comparative efficacy of generic nifedipine versus brand-name amlodipine for hypertension management in Taiwan. J. Clin. Hypertens (Greenwich), 24(7) : 870-877.
Dunham Morris J,A Morris J .2022 .. , : .
Lampert Slivnick J,BC Slivnick J .2019 .Hypertension and heart failure. Heart Fail Clin., 15(4) : 531-541.
Yin R,Yin L,Li L,Silva-Nash J,Tan J,Pan Z,Zeng J,Yan LL .2022 .Hypertension in China: Burdens, guidelines and policy responses: A state-of-the-art review. J. Hum Hypertens, 36(2) : 126-134.
Zaatari G,Fintel DJ,Subacius H,Germano JJ,Shani J,Goldberger JJ,Investigators JJ .2021 .Comparison of Metoprolol Versus Carvedilol After Acute Myocardial Infarction. Am. J. Cardiol., 147 : 1-7.
0

Citations

0

Downloads

91

Views